Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Acta Med Indones ; 53(1): 24-30, 2021 Jan.
Article En | MEDLINE | ID: mdl-33818404

BACKGROUND: alcohol may have additional neurotoxic ill-effects in patients with alcohol related cirrhosis apart from hepatic encephalopathy. We aimed to evaluate minimal hepatic encephalopathy (MHE) with Psychometric Hepatic Encephalopathy (PHES) score and Critical Flicker Frequency (CFF) in alcohol (ALD) and non-alcoholic steatohepatitis related (NASH) related cirrhosis. METHODS: 398 patients were screened between March 2016 and December 2018; of which 71 patients were included in ALD group and 69 in NASH group. All included patients underwent psychometric tests which included number connection test A and B (NCT-A and NCT-B), serial dot test (SDT), digit symbol test (DST), line tracing test (LTT) and CFF. MHE was diagnosed when their PHES was <-4. RESULTS: the prevalence of MHE was significantly higher in ALD group compared to NASH (69.01% vs 40.58%; P=0.007). The performance of individual psychometric tests was significantly poorer in ALD (P<0.05). Overall sensitivity and specificity of CFF was 76.62% (95%CI 65.59 - 85.52) and 46.03% (95%CI 33.39 - 59.06) respectively. Mean CFF was significantly lower in ALD than NASH (37.07 (SD 2.37) vs 39.05 (SD 2.40), P=0.001); also in presence of MHE (36.95 (SD 2.04) vs 37.96 (SD 1.87), P=0.033) and absence of MHE (37.34 (SD 3.01) vs 39.79 (SD 2.46), P=0.001). CONCLUSION: MHE is significantly more common in patients with ALD cirrhosis than NASH counterparts. Overall CFF values are less in alcohol related cirrhosis than NASH related cirrhosis, even in presence or absence of MHE. We recommend additional caution in managing MHE in ALD cirrhosis.


Hepatic Encephalopathy/diagnosis , Liver Cirrhosis/psychology , Non-alcoholic Fatty Liver Disease/psychology , Adult , Aged , Female , Hepatic Encephalopathy/epidemiology , Humans , Indonesia/epidemiology , Liver Cirrhosis/complications , Male , Middle Aged , Non-alcoholic Fatty Liver Disease/complications , Prevalence , Psychological Tests/statistics & numerical data , Psychometrics/methods , Reference Values , Sensitivity and Specificity , Severity of Illness Index , Young Adult
2.
J Pediatr Surg ; 56(11): 2005-2009, 2021 Nov.
Article En | MEDLINE | ID: mdl-33189296

BACKGROUND AND AIM: Device assisted enteroscopy is the cornerstone for small bowel evaluation. However, the data are limited in pediatric patients. In this study, we aim to evaluate the safety and utility of single balloon enteroscopy (SBE) in children. METHODS: The data of children (≤18-years) who underwent SBE from November 2010 to July 2020 was analyzed, retrospectively. The safety and diagnostic yield of SBE were assessed. RESULTS: 189-SBE procedures (males 117, mean age 15.1 ± 2.76, range 3-18 years) were performed in 174-children. The indications for SBE were chronic abdominal pain in 119 (68.4%), gastrointestinal bleed 17 (9.8%), chronic diarrhea 17 (9.8%) and vomiting 13 (7.5%). Antegrade, retrograde and combined SBE were performed in 98 (51.8%), 77 (40.7%), 7 (3.7%) children, respectively. The mean length of small bowel intubation in antegrade and retrograde SBE groups were 168.9 ± 58.6 cm and 120.7 ± 52.1 cm, respectively. Overall, a positive finding was seen in 117 (67.2%) cases. The most common findings were ileal and jejunal ulcers with or without strictures in 76 (64.9%) children. A total of 18 therapeutic enteroscopic procedures were performed. There were no major adverse events. CONCLUSION: SBE is a safe and effective procedure for the evaluation and management of small bowel diseases in children.


Intestinal Diseases , Single-Balloon Enteroscopy , Adolescent , Child , Child, Preschool , Double-Balloon Enteroscopy , Endoscopy, Gastrointestinal , Humans , Intestinal Diseases/diagnosis , Intestine, Small , Male , Retrospective Studies
...